Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ

Journal of Clinical Oncology

Volumn 34, Issue 33, 2016, Pages 4040-4046

  Morrow, Monica ^a   Van Zee, Kimberly J ^a   Solin, Lawrence J ^b   Houssami, Nehmat ⁱ   Chavez MacGregor, Mariana ^c   Harris, Jay R ^d   Horton, Janet ^e   Hwang, Shelley ^e   Johnson, Peggy L ^f   Marinovich, M Luke ⁱ   Schnitt, Stuart J ^d   Wapnir, Irene ^g   Moran, Meena S ^h  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b EINSTEIN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f Susan G Komen   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONSENSUS; EXCISION; HEALTH CARE COST; HUMAN; INTRADUCTAL CARCINOMA; MEDICAL SOCIETY; META ANALYSIS; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT INDICATION; TUMOR INVASION; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CONSENSUS DEVELOPMENT; FEMALE; MIDDLE AGED; PREVENTION AND CONTROL; SURGICAL ONCOLOGY; TUMOR RECURRENCE; UNITED STATES;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SOCIETIES, MEDICAL; SURGICAL ONCOLOGY; UNITED STATES;

EID: 84994779554     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.68.3573     Document Type: Article

References (37)

1. Correa C, McGale P, Taylor C, et al: Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010:162-177, 2010
2. Narod SA, Iqbal J, Giannakeas V, et al: Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1:888-896, 2015
3. Worni M, Akushevich I, Greenup R, et al: Trends in treatment patterns and outcomes for ductal carcinoma in situ. J Natl Cancer Inst 107:djv263, 2015
4. McCormick B, Winter K, Hudis C, et al: RTOG 9804: A prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 33:709-715, 2015
5. Houghton J, George WD, Cuzick J, et al: Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial. Lancet 362:95-102, 2003
6. Julien JP, Bijker N, Fentiman IS, et al: Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853. Lancet 355:528-533, 2000
7. Wapnir IL, Dignam JJ, Fisher B, et al: Longterm outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478-488, 2011
8. Emdin SO, Granstrand B, Ringberg A, et al: SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 45:536-543, 2006
9. Silverstein MJ, Lagios MD, Groshen S, et al: The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455-1461, 1999
10. Azu M, Abrahamse P, Katz SJ, et al: What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol 17:558-563, 2010
11. Morrow M, Jagsi R, Alderman AK, et al: Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302:1551-1556, 2009
12. King TA, Sakr R, Patil S, et al: Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29:2158-2164, 2011
13. Subhedar P, Olcese C, Patil S, et al: Decreasing recurrence rates for ductal carcinoma in situ: Analysis of 2996 women treated with breast-conserving surgery over 30 years. Ann Surg Oncol 22:3273-3281, 2015
14. Erratum Subhedar P, Olcese C, Patil S, et al: Decreasing recurrence rates for ductal carcinoma in situ: Analysis of 2996 women treated with breast-conserving surgery over 30 years. Ann Surg Oncol 22:S1618, 2015
15. Greenfield S, Steinberg EP, Auerbach A, et al: Clinical practice guidelines we can trust. http://www.nationalacademies.org/hmd/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust.aspx
16. Marinovich ML, Azizi L, Macaskill P, et al: The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: A meta-analysis. Ann Surg Oncol (in press)
17. Bland JM, Altman DG: Bayesians and frequentists. BMJ 317:1151-1160, 1998
18. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer 75:1310-1319, 1995
19. Donker M, Litière S, Werutsky G, et al: Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31:4054-4059, 2013
20. Faverly DR, Burgers L, Bult P, et al: Three dimensional imaging of mammary ductal carcinoma in situ: Clinical implications. Semin Diagn Pathol 11:193-198, 1994
21. Guidi AJ, Connolly JL, Harris JR, et al: The relationship between shaved margin and inked margin status in breast excision specimens. Cancer 79:1568-1573, 1997
22. Carter D: Margins of "lumpectomy" for breast cancer. Hum Pathol 17:330-332, 1986
23. Van Zee KJ, Subhedar P, Olcese C, et al: Relationship between margin width and recurrence of ductal carcinoma in situ: Analysis of 2996 women treated with breast-conserving surgery for 30 years. Ann Surg 262:623-631, 2015
24. Solin LJ, Gray R, Hughes LL, et al: Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol 33:3938-3944, 2015
25. Wong JS, Chen YH, Gadd MA, et al: Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). Breast Cancer Res Treat 143:343-350, 2014
26. Cuzick J, Sestak I, Pinder SE, et al: Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21-29, 2011
27. Bijker N, Meijnen P, Peterse JL, et al: Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381-3387, 2006
28. Pinder SE, Duggan C, Ellis IO, et al: A new pathological system for grading DCIS with improved prediction of local recurrence: Results from the UKCCCR/ANZ DCIS trial. Br J Cancer 103:94-100, 2010
29. Rakovitch E, Nofech-Mozes S, Hanna W, et al: A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Res Treat 152:389-398, 2015
30. Solin LJ, Gray R, Baehner FL, et al: A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 105:701-710, 2013
31. Bartelink H, Maingon P, Poortmans P, et al: Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol 16:47-56, 2015
32. Smith BD, Bentzen SM, Correa CR, et al: Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 81:59-68, 2011
33. Smith BD, Arthur DW, Buchholz TA, et al: Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74:987-1001, 2009
34. Moran MS, Schnitt SJ, Giuliano AE, et al: Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol 32:1507-1515, 2014
35. Edge SB, Byrd DR, Compton C, et al (eds): American Joint Committee on Cancer (AJCC) Cancer Staging Manual (ed 7). New York, NY, Springer, 2011
36. Li Y, Zhang S, Wei X, et al: The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective cohort study. Int J Surg 19:91-94, 2015
37. Parikh RR, Haffty BG, Lannin D, et al: Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. Int J Radiat Oncol Biol Phys 82:7-13, 2012